Cleared Traditional

M-LENS (THIRTY DEGREE ENDOSCOPE) (K873795) - FDA 510(k) Clearance

Class I Gastroenterology & Urology device.

K873795 · Opto Vision, Inc. · Gastroenterology & Urology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1988
Decision
119d
Days
Class 1
Risk

K873795 is an FDA 510(k) clearance for the M-LENS (THIRTY DEGREE ENDOSCOPE). Classified as Instrument, Special Lens, For Endoscope (product code FEI), Class I - General Controls.

Submitted by Opto Vision, Inc. (Chicago, US). The FDA issued a Cleared decision on January 14, 1988 after a review of 119 days - within the typical 510(k) review window.

This device falls under the Gastroenterology & Urology FDA review panel, regulated under 21 CFR 876.1500 - the FDA gastroenterology and urology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Gastroenterology & Urology review framework, consistent with the majority of Class II 510(k) submissions.

View all Opto Vision, Inc. devices

Submission Details

510(k) Number K873795 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 17, 1987
Decision Date January 14, 1988
Days to Decision 119 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
11d faster than avg
Panel avg: 130d · This submission: 119d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code FEI Instrument, Special Lens, For Endoscope
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 876.1500
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.